^
BIOMARKER:

TP53 mutation + KRAS mutation

i
Other names: KRAS, KRAS proto-oncogene GTPase, KRAS1, KRAS2, NS, NS3, OES, CFC2, RALD, K-Ras, RASK2, KI-RAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, K-Ras 2, C-K-RAS, c-Ki-ras, c-Ki-ras2, Kirsten rat sarcoma viral oncogene homolog, TP53, Tumor Protein P53, Cellular Tumor Antigen P53, Phosphoprotein P53, Tumor Protein P53, Antigen NY-CO-13, Transformation-Related Protein 53, Mutant Tumor Protein 53, P53 Tumor Suppressor, Tumor Suppressor P53, Tumor Protein 53, BMFS5, TRP53, BCC7, LFS1
Entrez ID:
TP53 mutation + KRAS mutation
NSCLC
Immunotherapy
Sensitive: B - Late Trials
TP53 mutation + KRAS mutation
LUAD
PD-L1 inhibitor
Sensitive: C3 – Early Trials
TP53 mutation + KRAS mutation
LUAD
PD1 inhibitor
Sensitive: C3 – Early Trials